儿童系统性红斑狼疮外周血淋巴细胞表面CTLA-4的表达及意义

doi:10.3969/j.issn.1006-3110.2016.11.030

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (554 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨外周血淋巴细胞表面CTLA-4在儿童系统性红斑狼疮(SLE)中的表达及意义。方法随机选取2012年1月-2015年9月在青岛市妇女儿童医院肾脏免疫科住院治疗的SLE患儿30例为SLE组,其中活动期16例,静止期14例。选择同期健康儿童30例为对照组。应用流式细胞仪技术测定两组外周血T淋巴细胞表面CD28、CTLA-4的表达水平。结果 SLE组患儿的外周血CD3⁺、CD4⁺及CD8⁺T 细胞上CD28的表达量与对照组比较,差异无统计学意义(均P＞0.05)。SLE组患儿的外周血CD3⁺、CD4⁺及CD8⁺T 细胞上CTLA-4表达均呈低水平,分别为(0.92±0.53)、(0.55±0.41)、(0.57±0.29)。其中SLE组患儿外周血CD3⁺、CD4⁺ T 细胞上CTLA-4分子的表达明显低于对照组(t=3.06、3.11,P＜0.05),CD8⁺T细胞上CTLA-4分子的表达亦低于对照组水平,但差异无统计学意义(t=0.84,P＞0.05)。活动期SLE组患儿外周血CD3⁺、CD4⁺T 细胞上CTLA-4分子的表达(分别为:0.74±0.47、0.41±0.24)明显低于对照组(t=3.40、4.48,均P＜0.05),CD8⁺T细胞上CTLA-4分子(0.47±0.29)的表达亦低于对照组水平(0.65±0.43),但差异无统计学意义(t=1.50,P＞0.05)。静止期SLE组患儿外周血CD3⁺、CD4⁺及CD8⁺T细胞上CTLA-4的表达量均较活动期SLE组患儿升高,且与对照组比较差异无统计学意义(均P＞0.05)。结论 SLE患儿外周血T 细胞中存在CTLA-4分子表达的缺陷,参与了SLE的发病过程;在SLE发病进展的过程中,CTLA-4表达明显降低,使得免疫反应相对激进,促使疾病的进一步发展。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王一冰
	崔广梅
	封东宁
	孙莉莉
	孙清

关键词 ：系统性红斑狼疮, 儿童, CTLA-4, 淋巴细胞

Abstract：Objective To explore the expression and value of CTLA-4 in peripheral blood lymphocytes of children with systematic lupus erythematosus (SLE). Methods Thirty children with SLE hospitalized in Department of Pediatric Nephrology, Qingdao Women and Children’s Hospital from January 2012 to September 2015 were randomly selected as SLE group, including 16 cases of active SLE and 14 cases of stationary SLE. 30 healthy children were simultaneously selected as the control group. The expression levels of CD28 and CTLA-4 in peripheral blood T lymphocytes of the 2 groups were tested by flow cytometry. Results No statistically significant difference was found in the expression of CD28 in peripheral blood CD3⁺, CD4⁺ and CD8⁺ T cells between SLE group and the control group (all P>0.05). The expression levels of CTLA-4 in peripheral blood CD3⁺, CD4⁺ and CD8⁺ T cells of SLE group were all low ((0.92±0.53), (0.55±0.41), (0.57±0.29)). The expression of CTLA-4 molecule in peripheral blood CD3⁺ and CD4⁺ T cells of SLE group was significantly lower than that of the control group (t=3.06, t=3.11, P<0.05), and the expression of CTLA-4 molecule in CD8⁺ T cells was also lower than that of the control group, but no statistically significant difference was found (t=0.84, P>0.05). The expression of CTLA-4 molecule in peripheral blood CD3⁺ and CD4⁺ T cells of active SLE group ((0.74±0.47), (0.41±0.24)) was significantly lower than that of the control group (t=3.40, t=4.48, both P<0.05), and the expression of CTLA-4 molecule in CD8⁺ T cells (0.47±0.29) was also lower than that of the control
group (0.65±0.43), but there was no statistically significant difference (t=1.50, P>0.05). The expression levels of CTLA-4 in peripheral blood CD3⁺, CD4⁺ and CD8⁺ T cells of stationary SLE group were all higher than those of active SLE group, but there was no statistically significant difference compared with the control group (all P>0.05). Conclusions There exists a defective expression of CTLA-4 molecule in the peripheral blood T cells from children with SLE; moreover, it is involved in the pathogenesis of SLE. The expression of CTLA-4 is significantly decreased in the pathogenesis and progress of SLE, which induces an active immune response and further development of the disease.

Key words： Systemic lupus erythematosus Children CTLA-4 Lymphocyte

收稿日期: 2016-03-21

R593.24+1

基金资助:青岛市2013年度医药科研指导计划(2013-WSZD083)

通讯作者: 孙清,E-mail:clg_lyh@163.com。

作者简介: 王一冰(1971-),男,研究生学历,副主任医师,研究方向:儿童肾脏免疫。

引用本文:

王一冰, 崔广梅, 封东宁, 孙莉莉, 孙清. 儿童系统性红斑狼疮外周血淋巴细胞表面CTLA-4的表达及意义[J]. 实用预防医学, 2016, 23(11): 1381-1384. WANG Yi-bing, CUI Guang-mei, FENG Dong-ning, SUN Li-li, SUN Qing. Expression and significance of CTLA-4 in peripheral blood lymphocytes of children with systematic lupus erythematosus. , 2016, 23(11): 1381-1384.

链接本文:

https://www.syyfyx.com/CN/10.3969/j.issn.1006-3110.2016.11.030 或 https://www.syyfyx.com/CN/Y2016/V23/I11/1381

[1] Feng JB,Ni JD,Yao X,et al.Gender and age influence on clinical and laboratory features in Chinese patients with systemic lupus erythematosus:1790 cases[J].Rheumatol Int,2010,30(8):1017-1023.
[2] Kamphuis S,Silverman ED.Prevalence and burden of pediatric-onset systemic lupus erythematosus[J].Nat Rev Rheumatol,2010,6(9):538-546.
[3] Chen Z,Zhou F,Huang S,et al.Association of cytotoxic T lymphocyte associated antigen-4 gene ( rs60872763 )polymorphism with Crohn＇s disease and high levels of serum sCTLA-4in Crohn’s disease[J].J Gastroenterol Hepatol,2011,26(5):924-930.
[4] Erfani N,Razmkhah M,Ghaderi A.Circulating soluble CTLA4( sCTLA4)is elevated in patients with breast cancer[J].Cancer Invest,2010,28(8):828-832.
[5] Bonmbardier C,Gladman DD,Urowiz MB,et al. Derivation of the SLEDAI:a diease activity index for lupus patients[J].Arthritis Reum,1992,35(4):630-640.
[6] 于清,薛海燕,曹兰芳.104 例儿童系统性红斑狼疮临床分析[J].临床儿科杂志, 2011,29(10):942-947.
[7] 郭雨凡,孙凌云,邹耀红,等.1958 例系统性红斑狼疮住院患者首发表现和起病特点的回顾分析[J].中华风湿病学杂志,2011,15(2):105-107.
[8] Tang Y,Chen Y,Ni B,et al.Up-regulation of the expression of costimulatory molecule CD40 in hepatocytes by hepatitis B virus X antigen[J].Biochem Biophys Res Commun,2009,384(1):12-17.
[9] 王淑琼,罗玮,姚勇利.青海汉族Graves病甲状腺肿大与CTLA-4基因多态性相关性研究[J].实用预防医学,2015,10(9):1136-1138.
[10] 周树录,李幼姬,叶任高.SLE患者Th1/Th2平衡状态及与外周血淋巴细胞CD28及CTLA-4分子表达的关系[J].中国病理生理杂志,2010, 26(8):1610-1615.
[11] 章圣辉,毕来喜,韩义香,等.CD28/CT LA-4 :B7 在特发性血小板减少性紫癜患者外周血淋巴细胞中的表达及意义[J].临床血液学杂志,2010,23(1):77-79.
[12] da Silva AE, dos Reis-Neto ET, da Silva NP, et al.The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus[J].Lupus, 2013, 22(14):1479-1483.